Key Highlights

• First Major US Retail Rollout: The mycelium-based Beyond Steak Filet launched at Wegmans and H-E-B stores, marking a significant retail milestone.

• Strong Nutritional Profile: The whole-cut plant-based steak delivers 28 grams of protein with just 1 gram of saturated fat per serving.

• Top-Selling DTC Product: The product has become the top-selling item on Beyond's direct-to-consumer platform.

Shares of Beyond Meat (NASDAQ: BYND) climbed about 9% on Tuesday and are up roughly 14% over the past week after the company launched its mycelium-based Beyond Steak Filet at Wegmans and H-E-B stores, marking its first major US retail rollout for the innovative product.

The whole-cut plant-based steak delivers 28 grams of protein with just 1 gram of saturated fat per serving, a nutritional profile that compares favorably to many traditional protein sources and addresses common consumer concerns about plant-based meat alternatives.

The product has become the top-selling item on Beyond's direct-to-consumer platform, providing early validation of consumer demand ahead of the broader retail expansion into major grocery chains like Wegmans and H-E-B.

This retail rollout is strengthening investor optimism that innovative products could help revive the company's growth after a challenging 2025, during which Beyond Meat faced significant headwinds across its broader plant-based protein portfolio.

The successful direct-to-consumer performance combined with the expansion into major regional grocery chains suggests the company may be finding a viable path to reignite growth through targeted product innovation rather than relying solely on its earlier, broader plant-based meat product lineup.

()